Liegh Nguyen, MBA

Liegh Nguyen joined Delix in August 2022 as the Head of Program Management, providing crucial support to Delix research and pre-clinical stage drug development programs, and working with project leads to ensure all goals, budget, activities, and resources are aligned.

Liegh brings 20 years of pharmaceutical/biotech experience focused on Program and Alliance Management at such companies as CureVac, Shire, and ARIAD Pharmaceuticals. She has overseen successful submissions of CTA, IND, and NDA, and a submission-ready premarket approval application for an in vitro diagnostic device.

Liegh received her Bachelor of Science in Biology from Boston College and her MBA from Simmons School of Management.